Lip Gregory Y H, Clementy Nicolas, Pierre Bertrand, Boyer Mathieu, Fauchier Laurent
University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, England; Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Service de Cardiologie, Pôle Coeur Thorax Vasculaire, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France.
Chest. 2015 Apr;147(4):1103-1110. doi: 10.1378/chest.14-2096.
Diabetes mellitus is recognized as a stroke risk factor in atrial fibrillation (AF). Patients with diabetes with retinopathy have an increased risk for systemic cardiovascular complications, and severe diabetic retinopathy predisposes to ocular bleeding. We hypothesized that patients with diabetes, retinopathy, and AF have increased stroke/thromboembolism (TE) and severe bleeding risks when compared with patients with diabetes and AF who do not have retinopathy or to patients with AF and without diabetes.
We tested our hypothesis in a large "real-world" cohort of individuals with AF from the Loire Valley Atrial Fibrillation project.
Of 8,962 patients with AF in our dataset, 1,409 (16%) had documented diabetes mellitus. Of these, 163 (1.8% of the whole cohort) were patients with diabetic retinopathy. After a follow-up of 31 ± 36 months, when compared with patients without diabetes, the risk of stroke/TE in patients with diabetes with no retinopathy increased 1.3-fold (relative risk [RR], 1.30; 95% CI, 1.07-1.59; P = .01); in patients with diabetes with retinopathy, the risk of stroke/TE was increased 1.58-fold (RR, 1.58; 95% CI, 1.07-2.32; P = .02). There was no significant difference when patients with diabetes with no retinopathy were compared with patients with diabetes with retinopathy (RR, 1.21; 95% CI, 0.80-1.84; P = .37). A similar pattern was seen for mortality and severe bleeding. On multivariate analysis, the presence of diabetic retinopathy did not emerge as an independent predictor for stroke/TE or severe bleeding.
Crude rates of stroke/TE increased in a stepwise fashion when patients without diabetes and with AF were compared with patients with diabetes with no retinopathy and patients with diabetes with retinopathy. However, we have shown for the first time, to our knowledge, that the presence of diabetic retinopathy did not emerge as an independent predictor for stroke/TE or severe bleeding on multivariate analysis.
糖尿病被认为是心房颤动(AF)患者发生中风的危险因素。患有视网膜病变的糖尿病患者发生全身性心血管并发症的风险增加,严重的糖尿病视网膜病变易导致眼部出血。我们推测,与没有视网膜病变的糖尿病合并AF患者或没有糖尿病的AF患者相比,患有糖尿病、视网膜病变和AF的患者发生中风/血栓栓塞(TE)及严重出血的风险增加。
我们在来自卢瓦尔河谷心房颤动项目的大量“真实世界”AF患者队列中检验了我们的假设。
在我们数据集中的8962例AF患者中,1409例(16%)有糖尿病记录。其中,163例(占整个队列的1.8%)为糖尿病视网膜病变患者。经过31±36个月的随访,与无糖尿病患者相比,无视网膜病变的糖尿病患者发生中风/TE的风险增加1.3倍(相对风险[RR],1.30;95%CI,1.07-1.59;P = 0.01);有视网膜病变的糖尿病患者发生中风/TE的风险增加1.58倍(RR,1.58;95%CI,1.07-2.32;P = 0.02)。无视网膜病变的糖尿病患者与有视网膜病变的糖尿病患者相比,差异无统计学意义(RR,1.21;95%CI,0.80-1.84;P = 0.37)。死亡率和严重出血情况也呈现类似模式。多变量分析显示,糖尿病视网膜病变的存在并未成为中风/TE或严重出血的独立预测因素。
将无糖尿病的AF患者与无视网膜病变的糖尿病患者及有视网膜病变的糖尿病患者进行比较时,中风/TE的粗发病率呈逐步上升趋势。然而,据我们所知,我们首次发现,在多变量分析中,糖尿病视网膜病变的存在并未成为中风/TE或严重出血的独立预测因素。